75 related articles for article (PubMed ID: 32713825)
1. Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study.
Hou N; Xiao J; Wang Z; Wu Y; Hou G; Guo L; Zhang J; Ling R
Clin Breast Cancer; 2020 Dec; 20(6):e682-e694. PubMed ID: 32713825
[TBL] [Abstract][Full Text] [Related]
2. Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
Ning L; Liu Y; He X; Han R; Xin Y; Zhao J; Liu X
Am J Clin Oncol; 2024 May; 47(5):228-238. PubMed ID: 38131531
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathological complete response of breast cancer patients who received neoadjuvant chemotherapy with a nomogram based on clinicopathologic variables, ultrasound, and MRI.
Zhang MQ; Liu XP; Du Y; Zha HL; Zha XM; Wang J; Liu XA; Wang SJ; Zou QG; Zhang JL; Li CY
Br J Radiol; 2024 Jan; 97(1153):228-236. PubMed ID: 38263817
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.
Qu F; Luo Y; Peng Y; Yu H; Sun L; Liu S; Zeng X
Front Immunol; 2023; 14():1335546. PubMed ID: 38274836
[TBL] [Abstract][Full Text] [Related]
5. Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue.
Zheng G; Hou J; Shu Z; Peng J; Han L; Yuan Z; He X; Gong X
BMC Med Imaging; 2024 Jan; 24(1):22. PubMed ID: 38245712
[TBL] [Abstract][Full Text] [Related]
6. Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors.
Zhang J; Xiao L; Pu S; Liu Y; He J; Wang K
Ann Surg Oncol; 2021 May; 28(5):2632-2645. PubMed ID: 33095360
[TBL] [Abstract][Full Text] [Related]
7. A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy.
Ma R; Wei W; Ye H; Dang C; Li K; Yuan D
BMC Cancer; 2023 Mar; 23(1):245. PubMed ID: 36918796
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
9. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy.
Şahin AB; Cubukcu E; Ocak B; Deligonul A; Oyucu Orhan S; Tolunay S; Gokgoz MS; Cetintas S; Yarbas G; Senol K; Goktug MR; Yanasma ZB; Hasanzade U; Evrensel T
Sci Rep; 2021 Jul; 11(1):14662. PubMed ID: 34282214
[TBL] [Abstract][Full Text] [Related]
10. Nomogram for Predicting Remission of Metabolic Syndrome 1 Year after Sleeve Gastrectomy Surgery in Chinese Patients with Obesity.
Pan Y; Han X; Tu Y; Zhang P; Yu H; Bao Y
Obes Surg; 2024 May; 34(5):1590-1599. PubMed ID: 38478194
[TBL] [Abstract][Full Text] [Related]
11. Nomogram Update to Predict the High Genomic Risk Breast Cancer by Different Races.
Wu P; Wu SG; He ZY
Clin Breast Cancer; 2024 Feb; 24(2):e61-e70.e3. PubMed ID: 38007348
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy.
Yang W; Yang Y; Zhang C; Yin Q; Zhang N
Magn Reson Imaging; 2024 May; 111():120-130. PubMed ID: 38703971
[TBL] [Abstract][Full Text] [Related]
13. Cost-effective prognostic evaluation of breast cancer: using a STAR nomogram model based on routine blood tests.
Wei C; Liang Y; Mo D; Lin Q; Liu Z; Li M; Qin Y; Fang M
Front Endocrinol (Lausanne); 2024; 15():1324617. PubMed ID: 38529388
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Nomogram for Predicting Mortality in Patients with Postoperative Bloodstream Infection in Surgical Intensive Care Unit.
Xiao Z; Sun Y; Zhao H; An Y
Int J Clin Pract; 2024; 2024():9911996. PubMed ID: 38250437
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram model for predicting the risk of MAFLD in the young population.
Yuan Y; Xu M; Zhang X; Tang X; Zhang Y; Yang X; Xia G
Sci Rep; 2024 Apr; 14(1):9376. PubMed ID: 38654043
[TBL] [Abstract][Full Text] [Related]
16. A nomogram to predict the risk of venous thromboembolism in patients with colon cancer in China.
Yang Y; Zhan J; Li X; Hua J; Lei H; Chen X
Cancer Med; 2024 May; 13(9):e7231. PubMed ID: 38698697
[TBL] [Abstract][Full Text] [Related]
17. A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012).
Maimaitiaili A; Li Y; Chai N; Liu Z; Ling R; Zhao Y; Yang H; Liu Y; Liu K; Zhang J; Mao D; Yu Z; Liu Y; Fu P; Wang J; Jiang H; Zhao Z; Tian X; Cao Z; Wu K; Song A; Jin F; Wu P; He J; Fan Z; Zhang H
Front Oncol; 2024; 14():1326385. PubMed ID: 38800388
[TBL] [Abstract][Full Text] [Related]
18. An ultrasound-based nomogram model in the assessment of pathological complete response of neoadjuvant chemotherapy in breast cancer.
Liu J; Leng X; Liu W; Ma Y; Qiu L; Zumureti T; Zhang H; Mila Y
Front Oncol; 2024; 14():1285511. PubMed ID: 38500656
[TBL] [Abstract][Full Text] [Related]
19. Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive/HER2-Negative Breast Cancer.
Xing D; Lv Y; Sun B; Chu T; Bao Q; Zhang H
Acad Radiol; 2024 Apr; ():. PubMed ID: 38641451
[TBL] [Abstract][Full Text] [Related]
20. Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer.
Zhang M; Zha H; Pan J; Liu X; Zong M; Du L; Du Y
Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38627192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
